BCL2 and neoplasm: In hepatocellular carcinoma, PCSK9 exhibits dual roles: it can promote tumor growth by inhibiting apoptosis through the Bax/Bcl-2/Caspase pathway [52] and also acts as a tumor suppressor by interacting with GSTP1 and inhibiting the c-Jun n-terminal kinase signaling pathway [53].